Calcium Chloride CALCIUM CHLORIDE REMEDYREPACK INC. FDA Approved 10% Calcium Chloride Injection, USP is a sterile, nonpyrogenic, hypertonic solution. Each mL contains 100 mg (1.4 mEq/mL) of calcium chloride, dihydrate (1.4 mEq each of Ca ++ and Cl - ) in water for injection. It is provided in a 10 mL Single-Dose Syringe to facilitate prompt intravenous injection. The solution contains no bacteriostat, antimicrobial agent or added buffer and is intended for use only as a single-dose injection. The pH of 10% Calcium Chloride Injection, USP is 5.5 to 7.5 when diluted with water for injection to make a 5% solution. May contain hydrochloric acid and/or sodium hydroxide for pH adjustment. The osmolar concentration is 2.04 mOsmol/mL (calc.). 10% Calcium Chloride Injection, USP is oxygen sensitive. Calcium Chloride, USP dihydrate is chemically designated CaCl 2 • 2H 2 O (dihydrate) and is described as white, odorless fragments or granules freely soluble in water.
FunFoxMeds bottle
Substance Calcium Chloride
Route
INTRAVENOUS INTRAVENTRICULAR
Applications
ANDA203477

Drug Facts

Composition & Profile

Strengths
10 % 10 unit 10 ml
Quantities
01 pack 1 pack 10 ml 1 ml
Treats Conditions
Indications And Usage 10 Calcium Chloride Injection Usp Is Indicated For The Treatment Of Hypocalcemia In Those Conditions Requiring A Prompt Increase In Plasma Calcium Levels

Identifiers & Packaging

Container Type BOTTLE
All Product Codes
UNII
M4I0D6VV5M
Packaging

HOW SUPPLIED 10% Calcium Chloride Injection, USP is supplied in single-dose containers as follows: One shrink wrapped package containing 10 unit cartons, each containing a Luer-Jet™ Luer-Lock Prefilled Syringe. NDC: 70518-4180-00 NDC: 70518-4180-01 PACKAGING: 10 in 1 PACKAGE PACKAGING: 1, 10 mL in 1 SYRINGE, TYPE 2 Store at 20° to 25°C (68° to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F). [See USP Controlled Room Temperature.] *CAUTION: IMPROPER ENGAGING MAY CAUSE GLASS BREAKAGE AND SUBSEQUENT INJURY. Repackaged and Distributed By: Remedy Repack, Inc. 625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762; DRUG: Calcium Chloride GENERIC: Calcium Chloride DOSAGE: INJECTION ADMINSTRATION: INTRAVENOUS NDC: 70518-4180-0 NDC: 70518-4180-1 PACKAGING: 10 mL in 1 SYRINGE OUTER PACKAGING: 10 in 1 PACKAGE ACTIVE INGREDIENT(S): CALCIUM CHLORIDE 100mg in 1mL INACTIVE INGREDIENT(S): SODIUM HYDROXIDE Hydrochloric Acid MM1 MM2

Package Descriptions
  • HOW SUPPLIED 10% Calcium Chloride Injection, USP is supplied in single-dose containers as follows: One shrink wrapped package containing 10 unit cartons, each containing a Luer-Jet™ Luer-Lock Prefilled Syringe. NDC: 70518-4180-00 NDC: 70518-4180-01 PACKAGING: 10 in 1 PACKAGE PACKAGING: 1, 10 mL in 1 SYRINGE, TYPE 2 Store at 20° to 25°C (68° to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F). [See USP Controlled Room Temperature.] *CAUTION: IMPROPER ENGAGING MAY CAUSE GLASS BREAKAGE AND SUBSEQUENT INJURY. Repackaged and Distributed By: Remedy Repack, Inc. 625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762
  • DRUG: Calcium Chloride GENERIC: Calcium Chloride DOSAGE: INJECTION ADMINSTRATION: INTRAVENOUS NDC: 70518-4180-0 NDC: 70518-4180-1 PACKAGING: 10 mL in 1 SYRINGE OUTER PACKAGING: 10 in 1 PACKAGE ACTIVE INGREDIENT(S): CALCIUM CHLORIDE 100mg in 1mL INACTIVE INGREDIENT(S): SODIUM HYDROXIDE Hydrochloric Acid MM1 MM2

Overview

10% Calcium Chloride Injection, USP is a sterile, nonpyrogenic, hypertonic solution. Each mL contains 100 mg (1.4 mEq/mL) of calcium chloride, dihydrate (1.4 mEq each of Ca ++ and Cl - ) in water for injection. It is provided in a 10 mL Single-Dose Syringe to facilitate prompt intravenous injection. The solution contains no bacteriostat, antimicrobial agent or added buffer and is intended for use only as a single-dose injection. The pH of 10% Calcium Chloride Injection, USP is 5.5 to 7.5 when diluted with water for injection to make a 5% solution. May contain hydrochloric acid and/or sodium hydroxide for pH adjustment. The osmolar concentration is 2.04 mOsmol/mL (calc.). 10% Calcium Chloride Injection, USP is oxygen sensitive. Calcium Chloride, USP dihydrate is chemically designated CaCl 2 • 2H 2 O (dihydrate) and is described as white, odorless fragments or granules freely soluble in water.

Indications & Usage

10% Calcium Chloride Injection, USP is indicated for the treatment of hypocalcemia in those conditions requiring a prompt increase in plasma calcium levels.

Dosage & Administration

10% Calcium Chloride Injection, USP is administered only by slow intravenous injection (not to exceed 1 mL/min), preferably in a central or deep vein . The usual precautions for intravenous therapy should be observed. If time permits, the solution should be warmed to body temperature. The injection should be halted if the patient complains of any discomfort; it may be resumed when symptoms disappear. Following injection, the patient should remain recumbent for a short time. The usual adult dosage in hypocalcemic disorders ranges from 200 mg to 1 g (2 -10 mL) at intervals of 1 to 3 days depending on the response of the patient and/or results of serum ionized calcium determinations. Repeated injections may be required because of rapid excretion of calcium. The pediatric dosage in hypocalcemic disorders ranges from 2.7 to 5.0 mg/kg hydrated calcium chloride (or 0.136 to 0.252 mEq elemental calcium per kg, or 0.027 to 0.05 mL of 10% Calcium Chloride Injection per kg). No data from clinical trials is available about repeated dosages, though textbook references recommend repeat dosages q 4 to 6 hours. Caution: 10% Calcium Chloride Injection consists of 1 gram of calcium chloride in a 10 mL syringe, or 100 mg/mL. This concentration represents 27 mg or 1.4 mEq of elemental calcium per mL. Thus, one 10 mL syringe provides 270 mg of elemental calcium. The dosage recommendation in various references is given either as amount of calcium chloride or amount of elemental calcium, and often it is not specified. Ionized calcium concentrations should be measured, to assist in dosage adjustment. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. See PRECAUTIONS . To prevent needle-stick injuries, needles should not be recapped, purposely bent or broken by hand.

Warnings & Precautions
No warnings available yet.
Adverse Reactions

Rapid injection may cause the patient to complain of tingling sensations, a calcium taste, a sense of oppression or “heat wave”. Injections of calcium chloride are accompanied by peripheral vasodilatation as well as a local “burning” sensation and there may be a moderate fall in blood pressure. Should perivascular infiltration occur, I.V. administration at that site should be discontinued at once. Local infiltration of the affected area with 1% procaine hydrochloride, to which hyaluronidase may be added, will often reduce venospasm and dilute the calcium remaining in the tissues locally. Local application of heat may also be helpful.


Similar Drugs

Related medications based on brand, generic name, substance, active ingredients.

View all similar drugs →